Evofem Biosciences announces last patient enrolled for AMPREVENCE, the phase 2b sexually transmitted infections trial of Amphora
July 2019Click for full info +
(2019, April 23). Cision PR Newswire.
- Unintended Pregnancy
URL of resource: